Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 25:14:1118529.
doi: 10.3389/fmicb.2023.1118529. eCollection 2023.

Communication of gut microbiota and brain via immune and neuroendocrine signaling

Affiliations
Review

Communication of gut microbiota and brain via immune and neuroendocrine signaling

Kaja Kasarello et al. Front Microbiol. .

Abstract

The gastrointestinal tract of the human is inhabited by about 5 × 1013 bacteria (of about 1,000 species) as well as archaea, fungi, and viruses. Gut microbiota is known to influence the host organism, but the host may also affect the functioning of the microbiota. This bidirectional cooperation occurs in three main inter-organ signaling: immune, neural, and endocrine. Immune communication relies mostly on the cytokines released by the immune cells into circulation. Also, pathogen-associated or damage-associated molecular patterns (PAMPs or DAMPs) may enter circulation and affect the functioning of the internal organs and gut microbiota. Neural communication relies mostly on the direct anatomical connections made by the vagus nerve, or indirect connections via the enteric nervous system. The third pathway, endocrine communication, is the broadest one and includes the hypothalamic-pituitary-adrenal axis. This review focuses on presenting the latest data on the role of the gut microbiota in inter-organ communication with particular emphasis on the role of neurotransmitters (catecholamines, serotonin, gamma-aminobutyric acid), intestinal peptides (cholecystokinin, peptide YY, and glucagon-like peptide 1), and bacterial metabolites (short-chain fatty acids).

Keywords: HPA axis; gut microbiota; gut-brain axis; immune system; vagus nerve.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Immune signaling between gut microbiota and central nervous system during eubiosis and dysbiosis. BBB, blood-brain barrier; CNS, central nervous system; DAMPs, damage-associated molecular patterns; IFNγ, interferon gamma; IL-2, interleukin-2; IL-10, interleukin 10; IL-12, interleukin 12; MMP9, matrix metallopeptidase 9; PAMPs, pathogen associated molecular patterns; TGFβ, transforming growth factor β; Th-1, T helper 1 cells; Th-17, T helper 17 cells; TNFα, tumor necrosis factor α; Tregs, regulatory T cells.
FIGURE 2
FIGURE 2
Influence of injured and inflamed central neurons system on gut microbiota. CNS, central nervous system; DAMPs, damage-associated molecular patterns; IL-10, interleukin 10; TGFβ, transforming growth factor β; Th-1, T helper 1 cells; Th-17, T helper 17 cells; Tregs, regulatory T cells.
FIGURE 3
FIGURE 3
The role of the vagus nerve in gut microbiota-brain communications. BBB, blood-brain barrier; CCK, cholecystokinin; DA, dopamine; GABA, gamma-aminobutyric acid; GLP-1, glucagon-like peptide-1; 5-HT, serotonin; LPS, lipopolysaccharide; NA, noradrenaline; PYY, peptide YY (PYY); SCFAs, short-chain fatty acids.
FIGURE 4
FIGURE 4
The role of the hypothalamic-pituitary-adrenal axis in gut microbiota-brain communications. ACTH, adrenocorticotropic hormone; CRF, corticotropin-releasing factor; HPA axis, hypothalamic-pituitary-adrenal axis; IL-1β, interleukin-1 beta; IL-6, interleukin 6; LPS, lipopolysaccharide; SCFAs, short-chain fatty acids; TNFα, tumor necrosis factor α.

References

    1. Abdel-Haq R., Schlachetzki J. C. M., Glass C. K., Mazmanian S. K. (2019). Microbiome-microglia connections via the gut-brain axis. J. Exp. Med. 216 41–59. 10.1084/jem.20180794 - DOI - PMC - PubMed
    1. Agahi A., Hamidi G. A., Daneshvar R., Hamdieh M., Soheili M., Alinaghipour A., et al. (2018). Does severity of Alzheimer’s disease contribute to its responsiveness to modifying gut microbiota? A double blind clinical trial. Front. Neurol. 9:662. 10.3389/fneur.2018.00662 - DOI - PMC - PubMed
    1. Ahlawat S., Asha, Sharma K. K. (2021). Gut-organ axis: A microbial outreach and networking. Lett. Appl. Microbiol. 72 636–668. 10.1111/lam.13333 - DOI - PubMed
    1. Akbari E., Asemi Z., Daneshvar Kakhaki R., Bahmani F., Kouchaki E., Tamtaji O. R., et al. (2016). Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: A randomized, double-blind and controlled trial. Front. Aging Neurosci. 8:256. 10.3389/fnagi.2016.00256 - DOI - PMC - PubMed
    1. Amiri P., Hosseini S., Ghaffari S., Tutunchi H., Ghaffari S., Mosharkesh E., et al. (2022). Role of Butyrate, a gut microbiota derived metabolite, in cardiovascular diseases: A comprehensive narrative review. Front. Pharmacol. 12:837509. 10.3389/fphar.2021.837509 - DOI - PMC - PubMed

LinkOut - more resources